Finance

Beta
Lists
IDIA:SWX
Idorsia Ltd
CHF 4.47
-6.69%
(-0.32) 1D
May 29, 5:31:09 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for IDIA...
Open
CHF 4.81
High
CHF 4.87
Low
CHF 4.42
Mkt. cap
1.14B
Avg. vol.
1.87M
Volume
2.88M
52-wk high
CHF 4.87
52-wk low
CHF 1.53
EPS
-CHF 1.28
Shares outstanding
255.04M
No. of employees
456
Open
CHF 4.81
High
CHF 4.87
Low
CHF 4.42
Mkt. cap
1.14B
Avg. vol.
1.87M
Volume
2.88M
52-wk high
CHF 4.87
52-wk low
CHF 1.53
EPS
-CHF 1.28
Shares outstanding
255.04M
No. of employees
456
News stories
From sources across the web
Profile
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
About Idorsia Ltd
CEO-
Employees456
Founded2017
Headquarters-
SectorBiotechnology
Websiteidorsia.com
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (CHF)
- / -
Revenue / Est. (CHF)
57.39M / 43.00M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
72.24M
41.49M
47.97M
57.39M
Cost of goods sold
26.04M
30.25M
36.94M
8.06M
Cost of revenue
26.04M
30.25M
36.94M
8.06M
Research and development expenses
-
-
-
23.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.08M
54.47M
63.45M
51.46M
Operating expense
48.44M
51.43M
62.84M
75.86M
Total operating expenses
74.48M
81.67M
99.78M
83.92M
Operating income
-2.24M
-40.19M
-51.81M
-26.53M
Other non operating income
-11.14M
14.54M
-31.45M
-19.80M
EBT including unusual items
-7.68M
-85.50M
-75.91M
-46.18M
EBT excluding unusual items
-4.23M
-50.34M
-65.08M
-46.32M
Income tax expense
3.70M
180.00K
1.85M
-486.00K
Effective tax rate
-48.21%
-0.21%
-2.44%
1.05%
Other operating expenses
-5.09M
-4.55M
-2.19M
-653.00K
Net income
-11.38M
-85.68M
-77.76M
-45.70M
Net profit margin
-15.75%
-206.52%
-162.09%
-79.62%
Earnings per share
-
-
-
-
Interest and investment income
200.00K
-
9.48M
-
Interest expense
-349.00K
-15.39M
-
-
Net interest expenses
-149.00K
-15.39M
9.48M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
2.70M
-36.04M
-47.78M
-22.77M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer